Patrick Jimonet

718 total citations
26 papers, 369 citations indexed

About

Patrick Jimonet is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Patrick Jimonet has authored 26 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 11 papers in Organic Chemistry. Recurrent topics in Patrick Jimonet's work include Neuroscience and Neuropharmacology Research (12 papers), Ion channel regulation and function (9 papers) and Synthesis and Biological Evaluation (6 papers). Patrick Jimonet is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Ion channel regulation and function (9 papers) and Synthesis and Biological Evaluation (6 papers). Patrick Jimonet collaborates with scholars based in France, United States and Belgium. Patrick Jimonet's co-authors include Serge Mignani, Alain Boireau, Robert De Jager, Jeremy Pratt, Eric Valeur, Dominique Damour, Marc Vuilhorgne, Jean‐Marie Stutzmann, Adam Doble and Thierry Canton and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

Patrick Jimonet

26 papers receiving 334 citations

Peers

Patrick Jimonet
Samuel David United States
Gian Luca Araldi United States
Sandy Hufeisen United States
Julie L. Engers United States
Anne Valade Belgium
David Thomae Belgium
Takayo Kida Japan
Nicholas A. Mitchell United States
Florian Montel Germany
Pekka Poutiainen Finland
Samuel David United States
Patrick Jimonet
Citations per year, relative to Patrick Jimonet Patrick Jimonet (= 1×) peers Samuel David

Countries citing papers authored by Patrick Jimonet

Since Specialization
Citations

This map shows the geographic impact of Patrick Jimonet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Jimonet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Jimonet more than expected).

Fields of papers citing papers by Patrick Jimonet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Jimonet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Jimonet. The network helps show where Patrick Jimonet may publish in the future.

Co-authorship network of co-authors of Patrick Jimonet

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Jimonet. A scholar is included among the top collaborators of Patrick Jimonet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Jimonet. Patrick Jimonet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jimonet, Patrick, Céline Druart, Stéphanie Blanquet‐Diot, et al.. (2024). Gut Microbiome Integration in Drug Discovery and Development of Small Molecules. Drug Metabolism and Disposition. 52(4). 274–287. 7 indexed citations
2.
Valeur, Eric & Patrick Jimonet. (2018). New Modalities, Technologies, and Partnerships in Probe and Lead Generation: Enabling a Mode-of-Action Centric Paradigm. Journal of Medicinal Chemistry. 61(20). 9004–9029. 24 indexed citations
3.
Mignani, Serge, Georg Andrees Böhme, Guillaume Birraux, et al.. (2002). 9-Carboxymethyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one-2-carbocylic Acid (RPR117824): Selective Anticonvulsive and Neuroprotective AMPA Antagonist. Bioorganic & Medicinal Chemistry. 10(5). 1627–1637. 27 indexed citations
4.
Canton, Thierry, Georg Andrees Böhme, Alain Boireau, et al.. (2001). RPR 119990, a Novel α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Antagonist: Synthesis, Pharmacological Properties, and Activity in an Animal Model of Amyotrophic Lateral Sclerosis. Journal of Pharmacology and Experimental Therapeutics. 299(1). 314–322. 33 indexed citations
5.
Jimonet, Patrick, Georg Andrees Böhme, Alain Boireau, et al.. (2001). Bioisosteres of 9-Carboxymethyl-4-oxo-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent In Vivo AMPA antagonists with longer durations of action. Bioorganic & Medicinal Chemistry Letters. 11(2). 127–132. 9 indexed citations
6.
Canton, Thierry, Alain Boireau, Serge Mignani, et al.. (2001). RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis.. PubMed. 299(1). 314–22. 57 indexed citations
7.
Stutzmann, J.M., Georg Andrees Böhme, Alain Boireau, et al.. (2001). Synthesis of anticonvulsive AMPA antagonists. Bioorganic & Medicinal Chemistry Letters. 11(9). 1205–1210. 5 indexed citations
8.
Jimonet, Patrick, Georg Andrees Böhme, Alain Boireau, et al.. (2000). 8-Methylureido-10-amino-10-methyl-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-ones: Highly In vivo Potent and Selective AMPA Receptor Antagonists. Bioorganic & Medicinal Chemistry. 8(8). 2211–2217. 3 indexed citations
9.
Stutzmann, J.M., Georg Andrees Böhme, Alain Boireau, et al.. (2000). 4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 10(10). 1133–1137. 14 indexed citations
10.
Pratt, Jeremy, Patrick Jimonet, Georg Andrees Böhme, et al.. (2000). Synthesis and potent anticonvulsant activities of 4-oxo-imidazo[1,2-a]indeno[1,2-e]pyrazin-8- and -9-carboxylic (acetic) acid AMPA antagonists. Bioorganic & Medicinal Chemistry Letters. 10(24). 2749–2754. 9 indexed citations
11.
12.
Mignani, Serge, Georg Andrees Böhme, Alain Boireau, et al.. (2000). 8-Methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno-[1,2-e]pyrazines: highly potent in vivo AMPA antagonists. Bioorganic & Medicinal Chemistry Letters. 10(6). 591–596. 9 indexed citations
13.
Jimonet, Patrick, Alain Boireau, Dominique Damour, et al.. (1999). Spiro-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives are mixed AMPA and NMDA glycine-site antagonists active in vivo. Bioorganic & Medicinal Chemistry Letters. 9(20). 2921–2926. 21 indexed citations
14.
Mignani, Serge, Michel Barreau, Alain Boireau, et al.. (1999). Synthesis and pharmacological properties of 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, a new competitive AMPA/KA receptor antagonist. Drug Development Research. 48(3). 121–129. 9 indexed citations
15.
Mignani, Serge, Dominique Damour, Michel Barreau, et al.. (1999). An Efficient Preparative Route to Fused Imidazo[1,2-a]pyrazin-4-one Derivatives. Heterocycles. 50(1). 259–259. 3 indexed citations
16.
Boireau, Alain, C. Malgouris, Marie‐Claude Burgevin, et al.. (1996). Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitro. European Journal of Pharmacology. 300(3). 237–246. 16 indexed citations
17.
Jimonet, Patrick, Magalie Barreau, J.C. Blanchard, et al.. (1994). Synthesis, anticonvulsant and neuroprotective activities of RP 66055, a riluzole derivative. Bioorganic & Medicinal Chemistry. 2(8). 793–798. 15 indexed citations
18.
Jimonet, Patrick, et al.. (1993). 1,2,4-Thiadiazino[3,4-b]benzothiazole: A New Cyclic Sulphenimine. Heterocycles. 36(12). 2745–2745. 2 indexed citations
19.
Mignani, Serge, et al.. (1992). Versatile Methods for the Synthesis of 2-Amino-6-trifluoromethoxy-(nitro)benzothiazoles. Synthetic Communications. 22(19). 2769–2780. 2 indexed citations
20.
Jimonet, Patrick, et al.. (1987). 2-Cyano Δ3 Piperideines XIV: Facile synthesis of 1-substituted benzomorphans. Tetrahedron Letters. 28(49). 6179–6182. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel David Breakdown of academic impact, for papers by Gian Luca Araldi Breakdown of academic impact, for papers by Sandy Hufeisen Breakdown of academic impact, for papers by Julie L. Engers Breakdown of academic impact, for papers by Anne Valade Breakdown of academic impact, for papers by David Thomae Breakdown of academic impact, for papers by Takayo Kida Breakdown of academic impact, for papers by Nicholas A. Mitchell Breakdown of academic impact, for papers by Florian Montel Breakdown of academic impact, for papers by Pekka Poutiainen
Rankless by CCL
2026